My primary interest is to understand the
mechanisms that lead to disease recurrence in acute leukemia with the overall
goal of preventing relapse. The goal of my current project is to identify
metabolic vulnerabilities in leukemia stem cells that can be therapeutically targeted
to prevent recurrent disease in AML. We are currently using global metabolomics
analysis to identify metabolic dependencies in leukemia stem cells.